Scientific Publications

Explore Thryv Therapeutics' scientific publications, alongside select reference publications from the broader scientific community. Our research is focused on advancing the understanding and treatment of cardiac arrhythmias and cardiometabolic disorders through selective SGK1 inhibition. We are contributing high-quality scientific evidence — from preclinical mechanism to clinical translation — that supports SGK1 inhibition as a precision approach to inherited and acquired disease.